January 28th 2025
From his own recovery to leading Illinois Recovery Center, Christopher Schenewerk, MD, shares he now champions peer support, naltrexone, and long-term care.
January 23rd 2025
Here's how best to manage polypharmacy in patients with traumatic brain injury.
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Expert Perspectives in the Recognition and Management of Postpartum Depression
View More
Southern California Psychiatry Conference
July 11-12, 2025
Register Now!
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists
View More
BURST CME™ Part I: Understanding the Impact of Huntington’s Disease
View More
Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease
View More
Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care
January 27th 2025Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.
Assessing Symptoms, Treatment Decision-Making, and Monitoring
January 27th 2025Panelists discuss when to adjust the dosage of current therapies like sertraline vs considering alternative treatments and the factors that guide these decisions, as well as whether treatments with rapid onset, such as zuranolone capsules or brexanolone intravenous (IV) infusion, would be appropriate for cases like Sarah’s, and what factors would influence the choice between these options.
A Case of PPD in a Mother With a History of Major Depressive Disorder
January 27th 2025Panelists discuss the case of Sarah, a 29-year-old woman with a history of major depressive disorder who is struggling with postpartum adjustment and increasing isolation, highlighting the challenges of transitioning into motherhood, family dynamics, and the potential genetic and environmental factors influencing her mental health.
CBT and the 2 Thieves: Regret for the Past and Fear of the Future, as per Charles Fulton Oursler
January 22nd 2025How does author Charles Fulton Oursler’s famous quote—'Many of us crucify ourselves between two thieves: regret for the past and fear of the future'—relates to modern cognitive behavioral therapy (CBT) and mindfulness?